Clinical Trials Logo

Clinical Trial Details — Status: Suspended

Administrative data

NCT number NCT05581095
Other study ID # IRBIS-19-0680
Secondary ID
Status Suspended
Phase N/A
First received
Last updated
Start date August 2023
Est. completion date September 2024

Study information

Verified date May 2023
Source University of North Carolina, Charlotte
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Primary Study Aims: 1. To evaluate the feasibility, acceptability, and preliminary efficacy of a 10-week mindful eating self-help program for women who binge eat during pregnancy. Primary efficacy targets will include measures of mindful eating and binge eating. Secondary efficacy targets will involve measures of body image and well-being. 2. To evaluate the incremental utility of adding use of a companion mindful eating smart phone application for enhancing the acceptability and preliminary efficacy of the program. 3. To gain insights into ways in which this program may be better tailored to the experiences of pregnancy for future program adaptation and refinement.


Description:

Research suggests that binge eating during pregnancy may adversely impact maternal-child health and well-being. For example, clinical evidence cites binge eating as a risk factor for increased gestational weight gain, cesarean delivery, giving birth to infants who are large for gestational age (LGA), and is associated with additional maternal susceptibility for cardiometabolic dysregulation and its complications at this critical maturational period . Nevertheless, surprisingly despite the growth in epidemiological investigations of eating disorders during pregnancy, no studies to date have specifically evaluated a behavioral intervention during pregnancy to address binge eating concerns within this population. Therefore, there is significant need to address this gap in order to develop, evaluate, and disseminate evidence-based behavioral interventions for women struggling with binge eating during pregnancy. One growing area of scholarship is implementing self-help approaches as a means of increasing availability to evidence-based behavioral health interventions for individuals who may not otherwise be able to access these treatments. At the same time, interventions that incorporate mindful eating have recently shown promise as an effective intervention for reducing binge eating and overeating in a wide range of clinical and community samples. These interventions most often conducted over a period ranging between 6-20 weeks of varying formats (e.g., group, in-person versus combination with remote support, etc.), and intensities (e.g., weekly versus bi-weekly, etc.), typically introduce participants to the concepts of mindfulness, provide opportunities to engage in mindfulness meditation practices, apply mindfulness skills to the process of eating via eating-related meditations and other similar exercises including appetite awareness training and encourage between-session home practice. The Am I Hungry? Mindful Eating Program for Binge Eating was used as a model for the present study. In the original pilot investigation a sample of women with binge eating disorder engaged in a 10-week group mindful eating-based treatment program. Results indicated significant reductions in binge eating severity and psychological distress by the final assessment period which were sustained at 1-year follow-up. We have adapted this approach in order to evaluate it in a guided self-help format with and without access to a companion smartphone application and among other things to directly assess not only changes in binge eating but also those related to more adaptive eating processes such as mindful and intuitive eating styles.


Recruitment information / eligibility

Status Suspended
Enrollment 50
Est. completion date September 2024
Est. primary completion date June 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria: - female (assigned sex at birth) - able to read and write in English - between the ages of 18-40 - lives in the United States - between 13-16 weeks pregnant (gestation) with a singleton - owns an iPhone or iPad - reports engaging in recurrent binge eating (i.e., reporting engaging in at least 1 binge eating episode per week for the last 28 days according to the EDE-Qi) - has access to a computer or tablet with Internet - being regularly followed by a healthcare provider during their pregnancy Exclusion Criteria: - reports current smoking or substance abuse - reports elevated depression (i.e., a score of 13 or higher on the EPDS) - reports current suicidal ideation (assessed on the EPDS) - reports anorexia, purging or compensatory behavior (both assessed on the EDE-Qi) - reports a history of being hospitalized for mental health treatment in the last 6 months - reports use of medications that are taken to affect appetite or metabolism (e.g., insulin) - is currently in therapy for treating binge eating - reports serious cardiovascular morbidity (e.g., hypertension) - reports uncontrolled or untreated thyroid disease - reports a history of 3 or more miscarriages, weakened cervix, or persistent bleeding during the first 12 weeks of pregnancy - reports being unable to commit to participate fully in the 10-week program (i.e., read from the self-help book weekly, utilize the smartphone application daily, submit weekly logs of their experiences) - individuals seeking a dieting approach to weight management during pregnancy

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Mindful Eating Self-Help Program
10-week exposure to mindful eating principles and practices outlined in the Eat What You Love, Love What You Eat for Binge Eating book
Mindful Eating Smartphone Application (Am I Hungry? Virtual Coach)
10-week exposure to using a mindful eating mobile phone application daily.

Locations

Country Name City State
United States UNC Charlotte Charlotte North Carolina

Sponsors (1)

Lead Sponsor Collaborator
University of North Carolina, Charlotte

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Enrollment percent enrollment within 6 months of opening recruitment 6 months after opening enrollment
Primary Attrition percent of participants who dropped out throughout the 10-week program
Primary Program Satisfaction participant satisfaction questionnaire after week 10
Primary App Usability app usability questionnaire after week 10
Primary Mindful Eating Mindful Eating Inventory (MEI) baseline, after week 5 (midpoint), after week 10 (immediate post)
Primary Binge Eating Eating Disorders Examination-Questionnaire with Instructions (EDE-Qi) baseline, after week 5 (midpoint), after week 10 (immediate post)
Primary Intuitive Eating Intuitive Eating Scale-2 (IES-2) baseline, after week 5 (midpoint), after week 10 (immediate post)
Secondary Body Image Body Image in Pregnancy Scale (BIPS) baseline, after week 5 (midpoint), after week 10 (post-program)
Secondary General Well-being General Well-being: Warwick-Edinburgh Mental Well-being Scale (WEMWBS) baseline, after week 5 (midpoint), after week 10 (post-program)
Secondary COVID-19-related Well-being Perinatal COVID-19-related Well-being (COPE-IU) baseline, after week 5 (midpoint), after week 10 (post-program)
Secondary Mindful Self-Care Mindful Self-Care Scale (MSCS) baseline, after week 5 (midpoint), after week 10 (immediate post)
Secondary Weight Bias Internalization Weight Bias Internalization Scale-Modified (WBIS-M) baseline, after week 5 (midpoint), after week 10 (immediate post)
Secondary Physical Activity International Physical Activity Questionnaire-Short Form (IPAQ-SF) baseline, after week 5 (midpoint), after week 10 (immediate post)
Secondary Depression Edinburgh Postnatal Depression Scale (EPDS) baseline, after week 5 (midpoint), after week 10 (immediate post)
See also
  Status Clinical Trial Phase
Completed NCT03442582 - Afluria Pregnancy Registry
Terminated NCT02161861 - Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study N/A
Not yet recruiting NCT05934318 - L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE) N/A
Enrolling by invitation NCT05415371 - Persistent Poverty Counties Pregnant Women With Medicaid N/A
Completed NCT04548102 - Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman N/A
Completed NCT03218956 - Protein Requirement During Lactation N/A
Completed NCT02191605 - Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy N/A
Completed NCT02223637 - Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
Recruiting NCT06049953 - Maternal And Infant Antipsychotic Study
Completed NCT02577536 - PregSource: Crowdsourcing to Understand Pregnancy
Not yet recruiting NCT06336434 - CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy Phase 1/Phase 2
Not yet recruiting NCT05412238 - Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months N/A
Not yet recruiting NCT04786587 - Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
Not yet recruiting NCT05028387 - Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
Completed NCT02783170 - Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women Phase 4
Completed NCT02683005 - Study of Hepatitis C Treatment During Pregnancy Phase 1
Recruiting NCT02619188 - Nutritional Markers in Normal and Hyperemesis Pregnancies N/A
Recruiting NCT02564250 - Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women N/A
Recruiting NCT02507180 - Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
Completed NCT02379728 - Ghana PrenaBelt Trial: A Positional Therapy Device to Reduce Still-Birth N/A